MARSHALL WACE, LLP - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 93 filers reported holding TREACE MED CONCEPTS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$426,482
-94.0%
32,531
-88.5%
0.00%
-93.3%
Q1 2023$7,126,375
+1260.0%
282,905
+1093.3%
0.02%
+1400.0%
Q3 2022$524,000
-17.2%
23,707
-30.1%
0.00%0.0%
Q4 2021$633,00033,9080.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q3 2022
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,595,387$36,677,9474.40%
EMERALD MUTUAL FUND ADVISERS TRUST 945,973$21,747,9191.35%
EMERALD ADVISERS, LLC 1,188,246$27,317,7761.32%
Perceptive Advisors 1,946,403$44,747,8051.26%
Novo Holdings A/S 637,317$14,651,9180.92%
SECTORAL ASSET MANAGEMENT INC 179,924$4,136,4530.80%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 493,213$11,338,9670.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 139,960$3,2180.50%
TimesSquare Capital Management, LLC 976,000$22,4380.32%
DRIEHAUS CAPITAL MANAGEMENT LLC 770,817$17,721,0830.26%
View complete list of TREACE MED CONCEPTS INC shareholders